Hepatitis C virus ribozymes
US6043077A · kind A · utility
53Cited by
3References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 1997 |
| Grant date | Mar 28, 2000 |
| Priority date | — |
| Expiry date | Oct 20, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides ribozymes useful to treat or prevent Hepatitis C Virus ("HCV") infection or disease in an organism or subject, as well as methods of treating an HCV infection or disease. Reagents such as vectors, host cells, DNA molecules coding for these ribozymes useful in methods of treatment and prevention of HCV infection or disease are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.